Found: 81
Select item for more details and to access through your institution.
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group.
- Published in:
- Supportive Care in Cancer, 2010, v. 18, n. 4, p. 509, doi. 10.1007/s00520-009-0744-x
- By:
- Publication type:
- Article
Lung Cancer in US Women: A Contemporary Epidemic.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 14, p. 1763, doi. 10.1001/jama.291.14.1763
- By:
- Publication type:
- Article
Predictors of Clinical Response of Non–Small Cell Cancer to Gefitinib—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 13, p. 1563, doi. 10.1001/jama.291.13.1563-b
- By:
- Publication type:
- Article
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer: A Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 16, p. 2149, doi. 10.1001/jama.290.16.2149
- By:
- Publication type:
- Article
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
- Published in:
- Nature Communications, 2017, v. 8, n. 7, p. 16078, doi. 10.1038/ncomms16078
- By:
- Publication type:
- Article
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 19, p. 1998, doi. 10.1001/jama.2014.3741
- By:
- Publication type:
- Article
Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.
- Published in:
- Clinical Trials, 2016, v. 13, n. 3, p. 331, doi. 10.1177/1740774515615540
- By:
- Publication type:
- Article
When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 20, p. 1534, doi. 10.1093/jnci/djs353
- By:
- Publication type:
- Article
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 23, p. 1624, doi. 10.1093/jnci/djp386
- By:
- Publication type:
- Article
Cisplatin Versus Carboplatin for Patients With Metastatic Non-Small-Cell Lung Cancer—An Old Rivalry Renewed.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 11, p. 828, doi. 10.1093/jnci/djk222
- By:
- Publication type:
- Article
Predicting Sensitivity of Non—Small-Cell Lung Cancer to Gefitinib: Is There a Role for P-Akt?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 15, p. 1117, doi. 10.1093/jnci/djh244
- By:
- Publication type:
- Article
Variations in Lung Cancer Risk Among Smokers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2003, v. 95, n. 6, p. 470, doi. 10.1093/jnci/95.6.470
- By:
- Publication type:
- Article
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.
- Published in:
- 2017
- By:
- Publication type:
- research
Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Acute chest pain syndrome during bleomycin infusions.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Immune biomarkers and response to checkpoint inhibition of BRAF<sup>V600</sup> and BRAF non-V600 altered lung cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase I trial of perillyl alcohol in patients with advanced solid tumors.
- Published in:
- 2003
- By:
- Publication type:
- journal article
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II Trials of the Serotonin Antagonist GR38032F for the Control of Vomiting Caused by Cisplatin.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 1, p. 42
- By:
- Publication type:
- Article
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRAS<sup>G12C</sup>-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 11, p. 978, doi. 10.1093/oncolo/oyad197
- By:
- Publication type:
- Article
Therapeutic Potential of Afatinib for Cancers with <italic>ERBB2</italic> (<italic>HER2</italic>) Transmembrane Domain Mutations G660D and V659E.
- Published in:
- Oncologist, 2018, v. 23, n. 2, p. 150, doi. 10.1634/theoncologist.2017-0345
- By:
- Publication type:
- Article
Complete Pathological Response to Crizotinib in a Patient with ALK-rearranged Lung Adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1253629
- By:
- Publication type:
- Article
Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2009, v. 133, n. 3, p. 470, doi. 10.5858/133.3.470
- By:
- Publication type:
- Article
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain.
- Published in:
- PLoS Medicine, 2005, v. 2, n. 3, p. 225, doi. 10.1371/journal.pmed.0020073
- By:
- Publication type:
- Article
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib.
- Published in:
- PLoS Medicine, 2005, v. 2, n. 1, p. 57, doi. 10.1371/journal.pmed.0020017
- By:
- Publication type:
- Article
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas.
- Published in:
- Nature Communications, 2022, v. 13, p. 1, doi. 10.1038/s41467-022-33719-6
- By:
- Publication type:
- Article
Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 90, p. 1, doi. 10.1126/scitranslmed.3002356
- By:
- Publication type:
- Article
Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 18, p. 3212, doi. 10.1002/cncr.29493
- By:
- Publication type:
- Article
Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 12, p. 2078, doi. 10.1002/cncr.29313
- By:
- Publication type:
- Article
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 3, p. 448, doi. 10.1002/cncr.29042
- By:
- Publication type:
- Article
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 2, p. 356, doi. 10.1002/cncr.27730
- By:
- Publication type:
- Article
Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 23, p. 5840, doi. 10.1002/cncr.27637
- By:
- Publication type:
- Article
Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Pack-Years of Cigarette Smoking as a Prognostic Factor in Patients With Stage IIIB/ IV Nonsmall Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 3, p. 670, doi. 10.1002/cncr.24813
- By:
- Publication type:
- Article
Phase 1 Trial of Everolimus and Gefitinib in Patients With Advanced Nonsmall-Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 599, doi. 10.1002/cncr.22816
- By:
- Publication type:
- Article
Management of Lung Cancer in Older Adults.
- Published in:
- CA: A Cancer Journal for Clinicians, 2003, v. 53, n. 6, p. 325, doi. 10.3322/canjclin.53.6.325
- By:
- Publication type:
- Article
Deep learning of cell spatial organizations identifies clinically relevant insights in tissue images.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43172-8
- By:
- Publication type:
- Article
Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Phase II Trials in Small-Cell Lung Cancer: Shouldn't We Be Doing Better?
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 14, p. 1058
- By:
- Publication type:
- Article
Dose-Ranging Trial of Zacopride: The Emetic Antiemetic?
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 9, p. 717
- By:
- Publication type:
- Article
The New Era in Lung Cancer Care.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 8, p. 302, doi. 10.46883/onc.3408.302
- By:
- Publication type:
- Article
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1079, doi. 10.1007/s00280-010-1265-5
- By:
- Publication type:
- Article